900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
von Willebrand factor only product	Preferred (foundation metadata concept)
von Willebrand factor only product in parenteral dose form	Preferred (foundation metadata concept)
von Willebrand factor products allergy	Preferred (foundation metadata concept)
von Willebrand factor products allergy (disorder)	Preferred (foundation metadata concept)
von Willebrand factor ristocetin cofactor	Acceptable (foundation metadata concept)
von Willebrand factor ristocetin cofactor	Preferred (foundation metadata concept)
von Willebrand factor ristocetin cofactor (substance)	Preferred (foundation metadata concept)
von Willebrand factor-containing product	Preferred (foundation metadata concept)
von Willebrand factor-containing product in parenteral dose form	Preferred (foundation metadata concept)
von Willebrand receptor	Preferred (foundation metadata concept)
von Willebrand receptor (substance)	Preferred (foundation metadata concept)
von Willebrand screening test	Preferred (foundation metadata concept)
von Willebrand screening test (procedure)	Preferred (foundation metadata concept)
von Willebrand's disease	Preferred (foundation metadata concept)
von Willebrand's disease	Acceptable (foundation metadata concept)
von Willebrand's disease (disorder)	Preferred (foundation metadata concept)
von Willebrand-Jurgens disease	Acceptable (foundation metadata concept)
von Willebrand-Jürgens disease	Acceptable (foundation metadata concept)
w	Preferred (foundation metadata concept)
w-Amidase	Preferred (foundation metadata concept)
w-Amidase (substance)	Preferred (foundation metadata concept)
w-Hydroxydecanoate dehydrogenase	Preferred (foundation metadata concept)
w-Hydroxydecanoate dehydrogenase (substance)	Preferred (foundation metadata concept)
w-Protein	Acceptable (foundation metadata concept)
w-hydroxylase	Acceptable (foundation metadata concept)
w/v	Preferred (foundation metadata concept)
w/w	Preferred (foundation metadata concept)
w1 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w10 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w11 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w12 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w13 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w14 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w15 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w16 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w17 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w18 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w19 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w2 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w20 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w21 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w3 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w4 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w5 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w6 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w7 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w8 specific IgE antibody measurement	Acceptable (foundation metadata concept)
w9 specific IgE antibody measurement	Acceptable (foundation metadata concept)
watt	Preferred (foundation metadata concept)
watt (qualifier value)	Preferred (foundation metadata concept)
watt/centimeter squared	Acceptable (foundation metadata concept)
weber	Preferred (foundation metadata concept)
weber (qualifier value)	Preferred (foundation metadata concept)
week	Preferred (foundation metadata concept)
week (qualifier value)	Preferred (foundation metadata concept)
weeks	Acceptable (foundation metadata concept)
weeks per month	Acceptable (foundation metadata concept)
weeks/month	Preferred (foundation metadata concept)
weeks/month (qualifier value)	Preferred (foundation metadata concept)
weeks/year	Preferred (foundation metadata concept)
weeks/year (qualifier value)	Preferred (foundation metadata concept)
wk	Acceptable (foundation metadata concept)
x	Preferred (foundation metadata concept)
x	Preferred (foundation metadata concept)
x (qualifier value)	Preferred (foundation metadata concept)
x trough	Preferred (foundation metadata concept)
x trough (qualifier value)	Preferred (foundation metadata concept)
x10(3)/mcL	Preferred (foundation metadata concept)
x10(3)/microliter	Acceptable (foundation metadata concept)
x10(3)/microliter (qualifier value)	Preferred (foundation metadata concept)
x10(6)/mcL	Preferred (foundation metadata concept)
x10(6)/microliter	Acceptable (foundation metadata concept)
x10(6)/microliter (qualifier value)	Preferred (foundation metadata concept)
y	Preferred (foundation metadata concept)
y	Preferred (foundation metadata concept)
y	Preferred (foundation metadata concept)
y (tumor staging)	Preferred (foundation metadata concept)
y - During therapy/following treatment	Preferred (foundation metadata concept)
y - During therapy/following treatment (tumor staging)	Preferred (foundation metadata concept)
y trough	Preferred (foundation metadata concept)
y trough (qualifier value)	Preferred (foundation metadata concept)
yard	Acceptable (foundation metadata concept)
yard/second	Acceptable (foundation metadata concept)
yards	Acceptable (foundation metadata concept)
yd	Preferred (foundation metadata concept)
yd/s	Preferred (foundation metadata concept)
yd2	Acceptable (foundation metadata concept)
yd3	Preferred (foundation metadata concept)
year	Preferred (foundation metadata concept)
year (qualifier value)	Preferred (foundation metadata concept)
years	Acceptable (foundation metadata concept)
yp grade - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
yp stage group - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
ypN - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
ypN0	Preferred (foundation metadata concept)
ypN0 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
ypN0(i+)	Preferred (foundation metadata concept)
ypN0(i+) - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
ypN0(mol+)	Preferred (foundation metadata concept)
ypN0(mol+) - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
ypN0a	Preferred (foundation metadata concept)

Start Previous Page 12701 of 12703 Next End

Reference Sets

Reference set descriptor

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)